Medical News

RSS

EMG and NCS reports performed by 'non-prequalified' physicians are found to be unreliable

In a recent study of workers’ compensation injury cases, Electromyography (EMG) and Nerve Conduction Studies (NCSs), which were performed by physicians who were not evaluated and pre-determined to meet a certain level of quality, were discovered to be highly unreliable.

26 Oct 2009

Pritzker Olsen to represent 3-year-old child sickened with an E. coli O157:H7 infection

Pritzker Olsen law firm has been retained to represent a 3-year-old child sickened with an E. coli O157:H7 infection and hemolytic uremic syndrome. The child is believed to have contracted the illness at a local apple orchard/ petting zoo in the Twin Cities (MN) area. Preliminary testing indicates that the genetic fingerprint of the E .coli O157:H7 obtained from the child’s stool sample matches the genetic fingerprint of E. coli from llama feces tested at the petting zoo.

26 Oct 2009

Cel Sci completes its production facility for Multikine Phase III clinical trial

BioMedReports, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, was given an exclusive tour of CEL-SCI Corporation's, new, state-of-the-art manufacturing facility near Baltimore, MD where the potentially ground breaking cancer immunotherapy treatment, Multikine, will be manufactured to support an upcoming Phase III clinical trial.

26 Oct 2009

UCSF presents update of Phase 2 clinical trial of Oncophage cancer vaccine at SNO 2009

Antigenics today announced that the Brain Tumor Research Center at the University of California, San Francisco (UCSF), has presented an update on a Phase 2 clinical trial of Oncophage (vitespen) for recurrent high grade glioma (brain cancer) at the 2009 Joint Meeting of SNO (Society for Neuro-Oncology) and AANS/CNS Section on Tumors 2009 in New Orleans, LA.

26 Oct 2009

Overview of Compugen’s DAC Blockers Platform presented at Fifth Peptide Engineering Meeting

Speaking today in Barcelona at the Fifth Peptide Engineering Meeting, Compugen Ltd. project manager Dr. Yossef Kliger provided an overview of Compugen’s DAC Blockers Platform and reviewed disease model data for selected product candidates.

26 Oct 2009

Winners of the EDCTP Award For Outstanding African Scientist

The European & Developing Countries Clinical Trials Partnership (EDCTP) has given its Awards for Outstanding African Scientist to Dr Alexis Nzila and Dr Dominique Pepper.

26 Oct 2009

Preliminary results for fiscal 2010 first quarter released by Rural/Metro

Rural/Metro Corporation, a leading provider of ambulance and private fire protection services, announced preliminary, unaudited results today for its fiscal 2010 first quarter.

26 Oct 2009

Anti-viral drug development programs progress successfully, reports NanoViricides

NanoViricides, Inc. (the "Company"), reports that the Company is well financed and its game changing anti-viral drug development programs are progressing successfully. As such, Management knows of no reason for the recent decline in stock price and associated volatility.

26 Oct 2009

CB&I signs definitive agreement with H2Gen Innovations to acquire PSA technology

CB&I (NYSE:CBI) announced today that it has entered into a definitive agreement with H2Gen Innovations, Inc., to acquire the Mars modularized Pressure Swing Adsorption (PSA) technology.

26 Oct 2009

Sunquest Information Systems achieves best ever results in fiscal year 2009 ending May 31

Sunquest Information Systems, Inc., a privately held market leader in laboratory and diagnostic information systems, today announced that the Fiscal Year 2009 ending May 31 was its most successful in the 30 year history of the company. This success is continuing into the new fiscal year, as sales orders for first quarter FY 2010, ending August 31, 2009 increased more than 30 percent compared to the same quarter a year ago.

26 Oct 2009

First Edition: October 26, 2009

Several Democratic senators voiced optimism on Sunday that Congress would pass a health care bill containing at least the germ of a government-run insurance program. Their expectations were grudgingly seconded by Senator John McCain, the Republican presidential candidate in 2008 (The New York Times).

26 Oct 2009

Insure.com renamed as Life Quotes; Nasdaq ticker symbol to be changed to QUOT

Insure.com, Inc. (Nasdaq: NSUR), announced today that it has completed its corporate name change to Life Quotes, Inc. The Company also announced that its Nasdaq ticker symbol will be changed to QUOT effective with the opening of the market on October 28, 2009.

26 Oct 2009

Appropriate diet lessens inflammation and muscular damage, leads to higher performance in competition sports

21 male skiers with an average age of 37 were studied and the results showed normal body weight as well as fat and muscle percentage and a predominantly athletic body build.

26 Oct 2009

Ingenuity Systems and Life Technologies develop new gene expression workflow for cell transcriptome analysis

Ingenuity Systems, the leading provider of information solutions for life science researchers, today announced it has developed a new gene expression workflow with Life Technologies Corporation.

26 Oct 2009

ZANTAC(R) Chili Challenge attracts thousands of Canadian participants

There are few dishes that bring out as much pride and passion from Canadians as chili. With football season and plunging temperatures in full swing, there is no better time for chili enthusiasts to get back into the kitchen, perfect their chili recipes and put them to the ultimate test in the second annual ZANTAC(R) Chili Challenge.

26 Oct 2009

Ceragenix Pharmaceuticals updates its cooperative research and development with MAST BioSurgery

Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the “Company”), a medical device company focused on infectious disease and dermatology, today provided an update to a previously announced exclusive cooperative research and development (the "Agreement”) with MAST BioSurgery Inc. (“MAST”) for the development of one or more new surgical products incorporating Ceragenix’s CeraShield™ antimicrobial technology.

26 Oct 2009

STAAR Surgical Company reports promising assessments from CAST

STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products today reported that the Collamer Accommodating Study Team (CAST) formed by the company in late 2008 has provided very promising initial patient vision assessments from the first phase of the project.

26 Oct 2009

New lightweight, elastic cloth seal for Obstructive Sleep Apnea patients

Circadiance, the leader in soft-cloth nasal CPAP masks, announces the new Zzzephyr Seal, a revolutionary elastic cloth seal designed to fit more comfortably over the patient's nose. The lightweight seal reduces air leakage, and helps to ensure a better night's sleep for Obstructive Sleep Apnea patients.

26 Oct 2009

Additional CFTR inhibitor technology licensed to Napo Pharmaceuticals

Napo Pharmaceuticals, Inc. has in-licensed from the University of California Regents additional small-molecule cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor technology including gastrointestinal (GI) and polycystic kidney disease (PKD) indications.

26 Oct 2009

AlterG M300 anti-gravity treadmill for physical therapy clinics, fitness and training facilities

AlterG, Inc., makers of the Anti-Gravity Treadmill, a revolutionary technology for rehabilitation and athletic training, today launched the AlterG M300. The M300 delivers the same anti-gravity technology originally developed at NASA and found in AlterG's P200 series, only at a third of the price and with a sleek new design.

26 Oct 2009

Medical News

EMG and NCS reports performed by 'non-prequalified' physicians are found to be unreliable

Pritzker Olsen to represent 3-year-old child sickened with an E. coli O157:H7 infection

Cel Sci completes its production facility for Multikine Phase III clinical trial

UCSF presents update of Phase 2 clinical trial of Oncophage cancer vaccine at SNO 2009

Overview of Compugen’s DAC Blockers Platform presented at Fifth Peptide Engineering Meeting

Winners of the EDCTP Award For Outstanding African Scientist

Preliminary results for fiscal 2010 first quarter released by Rural/Metro

Anti-viral drug development programs progress successfully, reports NanoViricides

CB&I signs definitive agreement with H2Gen Innovations to acquire PSA technology

Sunquest Information Systems achieves best ever results in fiscal year 2009 ending May 31

First Edition: October 26, 2009

Insure.com renamed as Life Quotes; Nasdaq ticker symbol to be changed to QUOT

Appropriate diet lessens inflammation and muscular damage, leads to higher performance in competition sports

Ingenuity Systems and Life Technologies develop new gene expression workflow for cell transcriptome analysis

ZANTAC(R) Chili Challenge attracts thousands of Canadian participants

Ceragenix Pharmaceuticals updates its cooperative research and development with MAST BioSurgery

STAAR Surgical Company reports promising assessments from CAST

New lightweight, elastic cloth seal for Obstructive Sleep Apnea patients

Additional CFTR inhibitor technology licensed to Napo Pharmaceuticals

AlterG M300 anti-gravity treadmill for physical therapy clinics, fitness and training facilities

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News